Skip to content
sellWeak10b5-1 plan

Kathleen Goin sold $342k of PVLA

Chief Operating Officer at PALVELLA THERAPEUTICS, INC.. 4,302 shares at an average of $79.40, traded Feb 18, 2026, filed Feb 20, 2026.

Warning score
20
Value
$342k
4,302 shares
Holdings after
0
-100% from before
From 52-week low
+323%
low $18.80, close $79.60
From 52-week high
-27%
high $109.07, as of Feb 18, 2026

Score components

  • Role
    COO
    +20
  • Trade size
    $342k at market
    +15
  • Share of holdings sold
    Sold 100% of holdings
    +20
  • Cluster
    No other insider selling within 14 days
    0
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +31.3%, 3m +33.1%, 6m +65.8%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

PVLAOct 12, 2026 · close 134.38
Since filing Feb 20, 2026: +56.9%SPY +13.7% · excess +43.1%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001104659-26-018136, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Feb 18, 2026MOption exercise
Common Stock10b5-1
+2,154$7.14$15k2,154Feb 20, 2026
Feb 18, 2026MOption exercise
Common Stock10b5-1
+2,148$9.08$20k4,302Feb 20, 2026
Feb 18, 2026SOpen-market sale
Common Stock10b5-1
-3,026$79.16$240k1,276Feb 20, 2026
Feb 18, 2026SOpen-market sale
Common Stock10b5-1
-1,276$79.97$102k0Feb 20, 2026
Feb 18, 2026MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-2,154$0.00$017,243Feb 20, 2026
Feb 18, 2026MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-2,148$0.00$017,184Feb 20, 2026

Related signals

Other insiders at PALVELLA THERAPEUTICS, INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
40Moderate
PVLAsell 310b5-1
PALVELLA THERAPEUTICS, INC.
Kathleen Goin
Chief Operating Officer
$655k
4,302 shares
-100%
40Moderate
PVLAsell 310b5-1
PALVELLA THERAPEUTICS, INC.
George M Jenkins
director
$4.2M
27,500 shares
-15%
42Moderate
PVLAsell 3
PALVELLA THERAPEUTICS, INC.
Christopher P Kiritsy
director
$49k
313 shares
-56%
33Weak
PVLAsell 210b5-1
PALVELLA THERAPEUTICS, INC.
Kathleen Goin
Chief Operating Officer
$655k
4,302 shares
-100%
25Weak
PVLAsell10b5-1
PALVELLA THERAPEUTICS, INC.
Kathleen Goin
Chief Operating Officer
$642k
4,302 shares
-100%
23Weak
PVLAsell10b5-1
PALVELLA THERAPEUTICS, INC.
Kathleen Goin
Chief Operating Officer
$476k
4,302 shares
-100%
23Weak
PVLAsell10b5-1
PALVELLA THERAPEUTICS, INC.
Kathleen Goin
Chief Operating Officer
$476k
4,302 shares
-100%
24Weak
PVLAsell10b5-1
PALVELLA THERAPEUTICS, INC.
Kathleen Goin
Chief Operating Officer
$547k
4,302 shares
-100%
26Weak
PVLAbuy
PALVELLA THERAPEUTICS, INC.
George M Jenkins
director
$50k
445 shares
+0%
23Weak
PVLAsell10b5-1
PALVELLA THERAPEUTICS, INC.
Kathleen Goin
Chief Operating Officer
$508k
4,302 shares
-100%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Kathleen Goin sold $342k of PVLA | InsiderTell